<!doctype html>

*|MC:SUBJECT|*

View this email in your browser
 
 

Legislation Introduced in US House to Protect Access to DXA!

HR 2693, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act has been introduced in the US House by Representatives John Larson (D-CT), Jackie Walorski (R-IN), Linda Sanchez (D-CA) and Susan Brooks (R-IN). This critical legislation will help combat the recent increase in hip fractures by ensuring access to DXA testing. Medicare cuts to DXA were followed by significant declines in DXA providers and DXA testing. Under this proposal, a floor on Medicare reimbursement for DXA would be set at $98, helping to ensure patient access to this important test.

We need to add co-sponsors to this critical proposal. This is where you come in. Please click here to send a quick, pre-drafted email today asking your members of the US House to co-sponsor HR 2693. As always, thank you for your continued support as we work to restore funding for DXA. Your involvement in these activities is an essential element of our advocacy efforts.

 

ASBMR Abstract Center is Now Open for Late-Breaking Research!

The deadline for late-breaking abstract submissions is Wednesday, June 5, 2019. A very limited number of abstracts will be accepted for oral presentation in Orlando, Florida, USA – others may be selected for poster presentation. With the fast pace of modern biomedical research, ASBMR recognizes that late-breaking findings of broad and exceptional importance may occur after our initial abstract deadline has passed, and that conclusions and data from important clinical trials may not have been available.  In order to present the most current research in the bone, mineral and musculoskeletal field, ASBMR extends an invitation to scientists in all sectors to submit abstracts on clinical, basic and translational subjects that describe novel, groundbreaking research findings of the highest scientific impact.

 

Congratulations to Benjamin Leder, M.D., for Winning the Golden Femur on Behalf of ASBMR in the ASBMR-ECTS Debate!

The bi-annual ASBMR-ECTS debate was held at the 46th annual meeting of the European Calcified Tissue Society, ECTS 2019, on Saturday, May 11th, in Budapest, Hungary. The topic of the debate was ‘This House Believes that Intervention to Increase Peak Bone Mass rather than Targeting Bone Loss Would be More Effective in Reducing the Osteoporosis Fracture’. The chairs of the debate were Bo Abrahamsen, M.D., Ph.D. (Denmark), Juliet Compston, M.D. (United Kingdom), and Anna Teti, Ph.D. (Italy). Arguing for the motion on behalf of ECTS was Nicholas Harvey, Ph.D. (United Kingdom), and arguing against the motion on behalf of ASBMR was Benjamin Leder, M.D. (United States). Dr. Leder won with 51% of the vote, and is pictured above with the miniature golden femur award. Congratulations again to Dr. Leder!

 

Apply Now for Amgen’s Competitive Grant Program in Bone Research – Deadline to Apply is June 28!


Amgen has launched a new Competitive Grant Program in Bone Research providing funding of up to $150,000 for novel research proposals that seek to improve quality of osteoporosis care patient outcomes.  An academic external panel comprised of internationally renowned experts will perform the assessment and selection of the research proposals eligible for funding, independently of Amgen. The call for proposals will close on June 28th, 2019. Click here for further information.
 

Apply Today for the Doris Duke Charitable Foundation 2019 Physician Scientist Fellowship!

The Doris Duke Charitable Foundation (DDCF) is seeking proposals from clinical investigators currently engaged in subspecialty fellowship training The 2019 DDCF Physician Scientist Fellowship consists of $100,000 direct costs plus $10,000 (10 percent) indirect costs each year for one to two years, depending on the need of the applicant. The award project period will begin on September 1, 2019. DDCF expects to fund between four and eight proposals in 2019. Click here for more information on eligibility criteria. The deadline to apply is June 7, 2019 at 3:00 PM ET.

 

Join ASBMR Members in Our National Osteoporosis Month Awareness Campaign!


May is National Osteoporosis Month, and this week ASBMR members are sharing their stories of how they are answering the call to action through research science and clinical practice. If you study osteoporosis or are involved in the care of patients with osteoporosis, ASBMR wants to hear about it and share your story! Members are encouraged to fill out this short form between now and May 31, 2019, and ASBMR will share your stories via Facebook and Twitter. The goal of this campaign is to help increase public awareness of osteoporosis and highlight the scientific advances that our community has made in the research of osteoporosis to date. Please take a moment and share with the world why the work you do changes lives.
 

It's National Osteoporosis Month - ARE YOU IN?


This is a special time for the ASBMR Fund for Research and Education.  Not only is it National Osteoporosis Month, it’s a time to celebrate bone health and an opportunity to make a difference for those who will lead the bone, mineral and musculoskeletal field in the future. 

BE IN and help build grant opportunities for our Young Investigators by donating to the Fund.  Watch the video above to learn directly from young investigators on the impact the ASBMR Fund for Research and Education has had on their careers.  Most importantly, every donation you give during the month of May will be matched dollar for dollar thanks to the ASBMR. Click here to make your donation today.
 

NIH ACD Working Group to Hold Public Listening Session to Hear from Victims of Sexual Harassment and Advocates Against Sexual Violence in the Workplace


The NIH Advisory Committee to the Director (ACD) Working Group on Changing the Culture to End Sexual Harassment will host a public listening session on Thursday, May 16, 3:00-4:30 p.m. EDT, to hear from victims of sexual harassment and advocates against sexual violence and for equal opportunity in the workplace. This listening session is an opportunity for the public to provide input to the Working Group as it develops recommendations to deliver to the ACD.  A facilitator will guide the conversation based on a series of questions. Attendees can provide input either publicly or anonymously. The listening session will be held in the NIH National Library of Medicine (Building 38A) Lister Hill Auditorium.  The listening session is free to attend, but registration is required. Please note that the listening session is not a forum for making or addressing allegations of sexual harassment. Additional information and registration can be found here. The listening session will also be available for viewing through NIH videocast.
 

Apply Now to Attend the 13th Fellows Forum on Metabolic Bone Diseases!


The Endocrine Fellows Foundation (EFF) and the American Society for Bone and Mineral Research (ASBMR) are pleased to offer fellows training in osteoporosis and other metabolic bone diseases a unique opportunity to participate in the Thirteenth Fellows Forum on Metabolic Bone Diseases, September 18-19, 2019 in Orlando, Florida.  The Forum will be held one day prior to the ASBMR 2019 Annual Meeting. Click here for more information and to apply for the program. The deadline to submit an application is Sunday, June 30, 2019.
 

Register Today for the ASBMR Webinar
"Skeletal Regeneration: Stem Cell Therapy"

There is no doubt that stem cells have captured the attention of both the scientific community and the public at large, and are touted to hold great promise for the fields of tissue engineering and regenerative medicine. Yet to date, there are very limited examples of success in using stem cells, including in the skeletal system. Dr. Pamela Robey will briefly review the history of skeletal stem cell/bone marrow stromal cell (SSC/BMSC) biology and their developmental origins. Dr. Robey will then describe the assays that have been developed that rigorously test for their functionality and their stemness (differentiation capacity and ability to self-renew). Lastly, Dr. Robey will describe how SSCs/BMSCs have been used in tissue engineering and regenerative medicine, the potential mechanisms of action, and hurdles that we face in bringing the promise of stem cell therapy to fruition. This webinar will be held on Friday, May 24 at 12:00 PM EDT. Click here to learn more and register!

 
JBMR® Highlights
Treatment of Autosomal Dominant Hypocalcemia Type 1 with the Calcilytic NPSP795 (SHP635)
Mary Scott Roberts, Rachel I. Gafni, Beth Brillante, Lori C. Guthrie, Jamie Streit, David Gash, Jeff Gelb, Eva Krusinska, Sarah C. Brennan, Martin Schepelmann, Daniela Riccardi, Mohd Ezuan Bin Khayat, Donald T. Ward, Edward F. Nemeth, Ralf Rosskamp, Michael T. Collins
First Published: 07 May 2019
 
Multimodal [18F]FDG PET/CT is a direct readout for inflammatory bone repair: a longitudinal study in TNFα transgenic mice
Silvia Hayer, Markus Zeilinger, Volker Weiss, Monika Dumanic, Markus Seibt, Birgit Niederreiter, Tetyana Shvets, Florian Pichler, Wolfgang Wadsak, Bruno K. Podesser, Thomas H. Helbich, Marcus Hacker, Josef S. Smolen, Kurt Redlich, Markus Mitterhauser
First Published: 07 May 2019

CTLA4‐Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages
Hiroyuki Okada, Hiroshi Kajiya, Yasunori Omata, Takumi Matsumoto, Yuiko Sato, Tami Kobayashi, Satoshi Nakamura, Yosuke Kaneko, Shinya Nakamura, Takuma Koyama, Shunichi Sudo, Masashi Shin, Fujio Okamoto, Hisato Watanabe, Naohiro Tachibana, Jun Hirose, Taku Saito, Toshiyuki Takai, Morio Matsumoto, Masaya Nakamura, Koji Okabe, Takeshi Miyamoto, Sakae Tanaka
First Published: 08 May 2019
JBMR® Plus Highlights
Effects of FES‐rowing Exercise on the Time‐Dependent Changes in Bone Microarchitecture after Spinal Cord Injury: A Cross‐Sectional Investigation
Adina E. Draghici, J. Andrew Taylor, Mary L. Bouxsein, Sandra J. Shefelbine
First Published: 08 May 2019

3‐(3‐hydroxyphenyl)‐Propionic Acid (PPA) Suppresses Osteoblastic Cell Senescence to Promote Bone Accretion in Mice
Jin‐Ran Chen, Umesh D. Wankhade, Alexander W. Alund, Michael L. Blackburn, Kartik Shankar, Oxana P. Lazarenko
First Published: 08 May 2019

How to build a bone: PHOSPHO1, biomineralization and beyond
Scott Dillon, Katherine A. Staines, José Luis Millán, Colin Farquharson
First Published: 10 May 2019
Bone Science in the News
Fracture risk tool useful in women with breast cancer initiating aromatase inhibitor therapy
Medical Xpress (5/9/2019)
 
Penn study reveals link between mitochondrial damage and osteoporosis
News-Medical.net (5/9/2019)
 
Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study
BMC Cancer (5/9/2019)
 
Knowledge gaps about long-term osteoporosis drug therapy benefits, risks remain large
Global Academy for Medical Education (5/1/2019)
Events Calendar
May 29 – June 1, 2019
Vitamin D Workshop
New York, NY, USA
 
May 30 – June 1, 2019
7th Seoul Symposium on Bone Health
Seoul, Republic of Korea
 
May 31 – June 1, 2019
Wisconsin Bone Club
Madison, WI, USA
 
June 6, 2019
NYU Center for Skeletal and Craniofacial Biology (CSCB) 2019 Symposium
New York, NY, USA
 
June 21, 2019
Symposium on Muscle-Bone Interaction in Duchenne Muscular Dystrophy 2019
Salzburg, Austria
Contact ASBMR
ASBMR Business Office
2025 M Street, NW
Suite 800
Washington, DC 20036-3309 USA
Tel.: +1 (202) 367-1161
Fax: +1 (202) 367-2161
Email: asbmr@asbmr.org


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list